The drug discovery portal: a computational platform for identifying drug leads from academia

Rachel Clark, Blair Johnston, Simon Mackay, Catherine Breslin, Murray Robertson, Oliver Brook Sutcliffe, Mark Dufton, Alan Harvey

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The Drug Discovery Portal (DDP) is a research initiative based at the University of Strathclyde in Glasgow, Scotland. It was initiated in 2007 by a group of researchers with expertise in virtual screening. Academic research groups in the university working in drug discovery programmes estimated there was a historical collection of physical compounds going back 50 years that had never been adequately catalogued. This invaluable resource has been harnessed to form the basis of the DDP library, and has attracted a highpercentage uptake from universities and research groups internationally. Its unique attributes include the diversity of the academic database, sourced from synthetic, medicinal and phytochemists working in academic laboratories and the ability to link biologists with appropriate chemical expertise through a target-matching virtual screening approach, and it has resulted in seven emerging hit development programmes between international contributors
LanguageEnglish
Pages1697-1702
Number of pages6
JournalCurrent Pharmaceutical Design
Volume16
Issue number15
DOIs
Publication statusPublished - May 2010

Fingerprint

Drug Discovery
Research
Pharmaceutical Preparations
Scotland
Libraries
Research Personnel
Databases

Keywords

  • virtual screening
  • academic drug discovery
  • natural products
  • chemical diversity
  • high-throughput
  • strategies
  • in-silico
  • chemical libraries

Cite this

@article{0fe21c216c574763bf2852b14a5ec1c8,
title = "The drug discovery portal: a computational platform for identifying drug leads from academia",
abstract = "The Drug Discovery Portal (DDP) is a research initiative based at the University of Strathclyde in Glasgow, Scotland. It was initiated in 2007 by a group of researchers with expertise in virtual screening. Academic research groups in the university working in drug discovery programmes estimated there was a historical collection of physical compounds going back 50 years that had never been adequately catalogued. This invaluable resource has been harnessed to form the basis of the DDP library, and has attracted a highpercentage uptake from universities and research groups internationally. Its unique attributes include the diversity of the academic database, sourced from synthetic, medicinal and phytochemists working in academic laboratories and the ability to link biologists with appropriate chemical expertise through a target-matching virtual screening approach, and it has resulted in seven emerging hit development programmes between international contributors",
keywords = "virtual screening, academic drug discovery, natural products, chemical diversity, high-throughput, strategies, in-silico, chemical libraries",
author = "Rachel Clark and Blair Johnston and Simon Mackay and Catherine Breslin and Murray Robertson and Sutcliffe, {Oliver Brook} and Mark Dufton and Alan Harvey",
year = "2010",
month = "5",
doi = "10.2174/138161210791164018",
language = "English",
volume = "16",
pages = "1697--1702",
journal = "Current Pharmaceutical Design",
issn = "1381-6128",
number = "15",

}

The drug discovery portal : a computational platform for identifying drug leads from academia. / Clark, Rachel; Johnston, Blair; Mackay, Simon; Breslin, Catherine; Robertson, Murray; Sutcliffe, Oliver Brook; Dufton, Mark; Harvey, Alan.

In: Current Pharmaceutical Design, Vol. 16, No. 15, 05.2010, p. 1697-1702.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The drug discovery portal

T2 - Current Pharmaceutical Design

AU - Clark, Rachel

AU - Johnston, Blair

AU - Mackay, Simon

AU - Breslin, Catherine

AU - Robertson, Murray

AU - Sutcliffe, Oliver Brook

AU - Dufton, Mark

AU - Harvey, Alan

PY - 2010/5

Y1 - 2010/5

N2 - The Drug Discovery Portal (DDP) is a research initiative based at the University of Strathclyde in Glasgow, Scotland. It was initiated in 2007 by a group of researchers with expertise in virtual screening. Academic research groups in the university working in drug discovery programmes estimated there was a historical collection of physical compounds going back 50 years that had never been adequately catalogued. This invaluable resource has been harnessed to form the basis of the DDP library, and has attracted a highpercentage uptake from universities and research groups internationally. Its unique attributes include the diversity of the academic database, sourced from synthetic, medicinal and phytochemists working in academic laboratories and the ability to link biologists with appropriate chemical expertise through a target-matching virtual screening approach, and it has resulted in seven emerging hit development programmes between international contributors

AB - The Drug Discovery Portal (DDP) is a research initiative based at the University of Strathclyde in Glasgow, Scotland. It was initiated in 2007 by a group of researchers with expertise in virtual screening. Academic research groups in the university working in drug discovery programmes estimated there was a historical collection of physical compounds going back 50 years that had never been adequately catalogued. This invaluable resource has been harnessed to form the basis of the DDP library, and has attracted a highpercentage uptake from universities and research groups internationally. Its unique attributes include the diversity of the academic database, sourced from synthetic, medicinal and phytochemists working in academic laboratories and the ability to link biologists with appropriate chemical expertise through a target-matching virtual screening approach, and it has resulted in seven emerging hit development programmes between international contributors

KW - virtual screening

KW - academic drug discovery

KW - natural products

KW - chemical diversity

KW - high-throughput

KW - strategies

KW - in-silico

KW - chemical libraries

U2 - 10.2174/138161210791164018

DO - 10.2174/138161210791164018

M3 - Article

VL - 16

SP - 1697

EP - 1702

JO - Current Pharmaceutical Design

JF - Current Pharmaceutical Design

SN - 1381-6128

IS - 15

ER -